Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|14|5|583-604

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.14, Iss.5, 2013-06, pp. : 583-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of multifunctional nanocarriers for delivery of anti-cancer therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 42, 2015-12 ,pp. : 6157-6164

Bentham Science Publishers

Access to resources Recommend Favorite

Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy

By  

Current Drug Targets, Vol. 19, Iss. 2, 2018-01 ,pp. : 170-180

Bentham Science Publishers

Access to resources Recommend Favorite

Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives

By  

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 131-134

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer carrier-linked prodrugs in clinical trials

By Kratz Felix   Abu Ajaj Khalid   Warnecke André  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 1037-1058

Informa Healthcare

Access to resources Recommend Favorite

Marine-derived anticancer agents in clinical trials

By Schwartsmann Gilberto   da Rocha Adriana Brondani   Mattei Jane   Lopes RafaelMartins  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1367-1383

Informa Healthcare

Access to resources Recommend Favorite